Cargando…

The risk of osteonecrosis of the jaw and adverse outcomes in patients using antiresorptive drugs undergoing orthodontic treatment: A systematic review

OBJECTIVES: Medication-related osteonecrosis of the jaw (MRONJ) is rare. It is a serious adverse effect of certain drugs, of which bisphosphonates (BPs) are the most widely known. The aim of this systematic review was to analyze all published evidence for the reported adverse outcomes as a result of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woolley, Julian, Akintola, Oladapo, Yates, Julian, Calasans-Maia, Monica Diuana, de Albuquerque Calasans-Maia, Jose, Kocherhina, Iryna, Sacco, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810783/ https://www.ncbi.nlm.nih.gov/pubmed/33490677 http://dx.doi.org/10.1016/j.heliyon.2021.e05914

Ejemplares similares

The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review
por: Sacco, Roberto, et al.
Publicado: (2021)

The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature
por: Sacco, Roberto, et al.
Publicado: (2023)

In Vivo Biological Evaluation of Orthodontically Moved Incisors after Replantation
por: Calasans-Maia, Jose de Albuquerque, et al.
Publicado: (2020)

In vivo osseointegration evaluation of implants coated with nanostructured hydroxyapatite in low density bone
por: Almeida, Daniel, et al.
Publicado: (2023)

The Use of Hydroxyapatite Loaded with Doxycycline (HADOX) in Dentoalveolar Surgery as a Risk-Reduction Therapeutic Protocol in Subjects Treated with Different Bisphosphonate Dosages
por: Sacco, Roberto, et al.
Publicado: (2022)

Does Melatonin Associated with Nanostructured Calcium Phosphate Improve Alveolar Bone Repair?
por: de Almeida, Camila Diuana, et al.
Publicado: (2022)

Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents
por: Rodriguez-Lozano, Francisco-Javier, et al.
Publicado: (2016)

Early osseointegration driven by the surface chemistry and wettability of dental implants
por: SARTORETTO, Suelen Cristina, et al.
Publicado: (2015)

Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw
por: Kim, Ha Young
Publicado: (2021)

The Influence of Nanostructured Hydroxyapatite Surface in the Early Stages of Osseointegration: A Multiparameter Animal Study in Low-Density Bone
por: Sartoretto, Suelen Cristina, et al.
Publicado: (2020)

Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
por: Taguchi, Akira, et al.
Publicado: (2017)

Alveolar bone repair with strontium- containing nanostructured carbonated hydroxyapatite
por: do Carmo, André Boziki Xavier, et al.
Publicado: (2018)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)()
por: Baba, Akira, et al.
Publicado: (2019)

Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature
por: Pimolbutr, Kununya, et al.
Publicado: (2018)

In Vivo Evaluation of Permeable and Impermeable Membranes for Guided Bone Regeneration
por: Sartoretto, Suelen Cristina, et al.
Publicado: (2022)

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS
por: Anastasilakis, Athanasios D, et al.
Publicado: (2021)

Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan
por: Kunihara, Takahiro, et al.
Publicado: (2023)

Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database
por: Peng, Jing, et al.
Publicado: (2022)

The Effect of Antiresorptive Drug Holidays on Medication-Related Osteonecrosis of the Jaw: A Systematic Review and Meta-Analysis
por: Aboalela, Ali A, et al.
Publicado: (2022)

SHEEP AS AN EXPERIMENTAL MODEL FOR BIOMATERIAL IMPLANT EVALUATION
por: SARTORETTO, SUELEN CRISTINA, et al.
Publicado: (2016)

Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
por: Dalle Carbonare, Luca, et al.
Publicado: (2021)

Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage
por: Watanabe, Takuma, et al.
Publicado: (2021)

Relationship between Drug Holidays of Antiresorptive Agents and Surgical Outcomes in Cancer Patients with Medication-Related Osteonecrosis of the Jaw
por: Otsuru, Mitsunobu, et al.
Publicado: (2022)

Medication-Related Osteonecrosis of the Jaw in Patients Treated Concurrently with Antiresorptive and Antiangiogenic Agents: Systematic Review and Meta-Analysis
por: Srivastava, Akanksha, et al.
Publicado: (2021)

Relationship between drug holiday of the antiresorptive agents and surgical outcome of medication-related osteonecrosis of the jaw in osteoporosis patients
por: Morishita, Kota, et al.
Publicado: (2022)

Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan
por: Nashi, Masanori, et al.
Publicado: (2023)

Osseodensification enables bone healing chambers with improved low-density bone site primary stability: an in vivo study
por: Mello-Machado, Rafael Coutinho, et al.
Publicado: (2021)

Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?
por: Oteri, Giacomo, et al.
Publicado: (2018)

Predictive Value of Neutrophil–Lymphocyte Ratio as a Marker in Antiresorptive Agent-Related Osteonecrosis of the Jaw: A Retrospective Analysis
por: Kurohara, Kazuto, et al.
Publicado: (2022)

Location and Gender Differences in Osteonecrosis of the Jaws in Patients Treated with Antiresorptive and Antineoplastic Drugs Undergoing Dentoalveolar Surgical, Systematic Review with Meta-Analysis and Trial Sequential Analysis
por: Dioguardi, Mario, et al.
Publicado: (2023)

Nanostructured Carbonated Hydroxyapatite Associated to rhBMP-2 Improves Bone Repair in Rat Calvaria
por: Schneider Werner Vianna, Thiago, et al.
Publicado: (2020)

In Vivo Comparative Evaluation of Biocompatibility and Biodegradation of Bovine and Porcine Collagen Membranes
por: Neto, Abdu Mansur Dacache, et al.
Publicado: (2020)

Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: A case-control study
por: Pedersen, Alma B., et al.
Publicado: (2022)

Medication‐related osteonecrosis of the jaw and successful implant treatment in a patient on high‐dose antiresorptive medication: A case report
por: Ottesen, Camilla, et al.
Publicado: (2022)

Histopathological findings affect quantitative values of single photon emission computed tomography in patients with antiresorptive agent-related osteonecrosis of the jaws
por: Okui, Taro, et al.
Publicado: (2023)

Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience
por: Favia, Gianfranco, et al.
Publicado: (2016)

Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review
por: Ottesen, Camilla, et al.
Publicado: (2020)

Intraoral localized methotrexate‐associated lymphoproliferative disorders concurrent with antiresorptive agent‐related osteonecrosis of the jaw: A case report and literature review
por: Minabe, Masaki, et al.
Publicado: (2020)

Response to Letter to the Editor From Taguchi: “Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS”
por: Anastasilakis, Athanasios D, et al.
Publicado: (2022)

Osteonecrosis of the Jaw
por: Lončar Brzak, Božana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hr5hltcm2g9gmhk265n3vs38th